Animesh Pardanani - Concepedia

Author

Animesh Pardanani

Also Known As

A D Pardanani, A Pardanani, A. D. Pardanani, A. PARDANANI, A. Pardanani, Animesh D Pardanani, Animesh D. Pardanani, Animesh Dev Pardanani, Animesh Pardanani, Christine Mclaren

805

Publications

39.9K

Citations

102

H-Index

159

Concepts

All Affiliations

Mayo Clinic in Arizona Mayo Clinic WinnMed Mayo Clinic in Florida The University of Texas MD Anderson Cancer Center

About

Animesh Pardanani is an author at Mayo Clinic in Arizona specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	54	115	10.8K
2	Health Sciences	17	21	1.3K
3	Public Health	12	12	607
4	Engineering	5	5	476
5	Natural Sciences	3	3	133

Animesh Pardanani

286

Publications

30.3K

Citations

H-Index

Page 1

	Year	Citations
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis Srđan Verstovšek, Hagop M. Kantarjian, Ruben A. Mesa, New England Journal of Medicine	2010	1.2K
MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients Animesh Pardanani, Ross L. Levine, Terra L. Lasho, Blood	2006	1K
DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status Naseema Gangat, Domenica Caramazza, Rakhee Vaidya, Journal of Clinical Oncology	2010	1K
Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet Tiziano Barbui, Giovanni Barosi, Gunnar Birgegård, Journal of Clinical Oncology Mixed-phenotype Acute LeukemiaEuropean LeukemianetPathologyTumor BiologyMyeloid Neoplasia	2011	825
Mutations and prognosis in primary myelofibrosis A. M. Vannucchi, T L Lasho, Paola Guglielmelli, Leukemia Hematological MalignancyHematologyPathologyMolecular DiagnosticsMyelopoiesis	2013	739
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis Ayalew Tefferi, Paola Guglielmelli, Dirk R. Larson, Blood	2014	712
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study Ayalew Tefferi, Elisa Rumi, Guido Finazzi, Leukemia	2013	653
Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study Ayalew Tefferi, Rakhee Vaidya, Domenica Caramazza, Journal of Clinical Oncology	2011	578
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors Ken-Hong Lim, Ayalew Tefferi, Terra L. Lasho, Blood	2009	567
CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons Ayalew Tefferi, Terra L. Lasho, Christy M. Finke, Leukemia Hematological MalignancyOncologyMedicineHematologyPathology	2014	535

Page 1